Carisma Therapeutics Inc (CARM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 9,197 | 3,397 | 4,289 | 3,827 | 3,560 |
| Gross Profit | 9,197 | 3,397 | 4,289 | 3,827 | 3,560 |
| Operating Expenses | 20,867 | 22,907 | 26,739 | 26,171 | 24,525 |
| Operating Income | -11,670 | -19,510 | -22,450 | -22,344 | -20,965 |
| Other Income | 508 | 532 | 1,295 | 941 | 1,177 |
| Pre-tax Income | -11,162 | -18,978 | -21,155 | -21,403 | -19,788 |
| Income Tax | N/A | N/A | N/A | N/A | 88 |
| Net Income Continuous | -11,162 | -18,978 | -20,958 | -21,403 | -19,876 |
| Net Income | $-11,162 | $-18,978 | $-20,958 | $-21,403 | $-19,876 |
| EPS Basic Total Ops | -0.27 | -0.46 | 0.36 | -0.53 | -0.49 |
| EPS Basic Continuous Ops | -0.27 | -0.46 | 0.36 | -0.53 | -0.49 |
| EPS Diluted Total Ops | -0.27 | -0.46 | 0.36 | -0.53 | -0.49 |
| EPS Diluted Continuous Ops | -0.27 | -0.46 | 0.36 | -0.53 | -0.49 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.46 | -0.52 | N/A | N/A |
| EBITDA(a) | $-11,415 | $-17,817 | $-21,728 | $-21,649 | $-20,250 |